InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Autonomix Medical, Inc.

AMIX Clue Score40
United States Fiscal year ends March CIK 0001617867
$3.11 -0.64% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.11 +146.83% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 29 Jan 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue0.0Operating income−2.0Net income−2.0Fiscal year 2024Revenue0.0Operating income−12.0Net income−15.4Fiscal year 2025Revenue0.0Operating income−11.6Net income−11.4Fiscal year 2026Revenue0.0Operating income−17.0Net income−16.7
FY2023FY2024FY2025FY2026
Revenue 0.0 0.0 0.0 0.0
Growth
Operating income −2.0 −12.0 −11.6 −17.0
Net income −2.0 −15.4 −11.4 −16.7
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−1.9Capital expenditure0.0Free cash flow−1.9Fiscal year 2024Operating cash flow−6.6Capital expenditure−0.0Free cash flow−6.6Fiscal year 2025Operating cash flow−8.3Capital expenditure−0.0Free cash flow−8.3Fiscal year 2026Operating cash flow−12.3Capital expenditure−0.0Free cash flow−12.3
FY2023FY2024FY2025FY2026
Operating cash flow −1.9 −6.6 −8.3 −12.3
Capital expenditure 0.0 −0.0 −0.0 −0.0
Free cash flow −1.9 −6.6 −8.3 −12.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash0.9Total debt0.0Net cash (debt)0.9Shareholders’ equity0.6Debt to equity0.00Fiscal year 2024Cash8.6Shareholders’ equity7.6Fiscal year 2025Cash9.1Shareholders’ equity8.1Fiscal year 2026Cash7.0Shareholders’ equity5.9
FY2023FY2024FY2025FY2026
Cash 0.9 8.6 9.1 7.0
Total debt 0.0 n/a n/a n/a
Net cash (debt) 0.9 n/a n/a n/a
Shareholders’ equity 0.6 7.6 8.1 5.9
Debt to equity 0.00 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Revenue and profit
0.0 0.0 0.0 0.0
Growth
0.7 2.2 4.7 7.1
1.2 5.2 6.9 9.9
−2.0 −12.0 −11.6 −17.0
Growth
−2.0 −15.4 −11.4 −16.7
0.0 0.0 0.0 0.0
−2.0 −15.4 −11.4 −16.7
Growth
Per share
−0.17 −14.82 −6.46 −2.32
12.0 1.0 1.8 7.2

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.